BMPR2 and pulmonary arterial hypertension: Notably, the lysosomal inhibitor chloroquine attenuates autophagy and degradation of bone morphogenetic protein type II receptor, a key player in human PAH, and has been shown to reverse pulmonary vascular remodeling and hemodynamics in monocrotaline- or hypoxia-induced PH in rats (23, 36).